Last reviewed · How we verify

NCT04356898: RFGM

Ramadan Flash Glucose Monitoring Study

Completed Last updated 24 April 2020
What this trial tests

trial testing No intervention in Diabetes Mellitus in 321 participants. Completed in 31 December 2019.

Timeline
15 April 2018
Primary endpoint
31 March 2019
31 December 2019

Quick facts

Lead sponsorImperial College London Diabetes Centre
StatusCompleted
Study typeOBSERVATIONAL
Enrollment321
Start date15 April 2018
Primary completion31 March 2019
Estimated completion31 December 2019
Sites2 locations across United Arab Emirates

Drugs / interventions tested

Conditions studied

Sponsor

Imperial College London Diabetes Centre

Who can join

Adults 18 to 65, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Many Muslim patients with diabetes observe dawn to sunset fasting during the month of Ramadan. Hyperglycaemia and hypoglycaemia are possible problems amongst these patients. The aim of this study is to investigate glucose profiles in diabetes and non-diabetes patients that decided to fast or not to fast during Ramadan.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

Other Imperial College London Diabetes Centre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04356898.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing